BFNHOTCLaboratory Analytical InstrumentsFiscal year ends December 31
BIOFORCE NANOSCIENCES HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$6.87−0.04 (-0.58%)
Close on Oct 19, 2026
- Market cap
- $230.52M
- P/E (TTM)
- 687.2
- Dividend yield
- –
Ownership
Who owns Bioforce Nanosciences's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 1 sales
Net sold $534.00K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Nexus Capital Investments, Inc. | 26,700,000 | 79.60% | 13D (active) | Apr 22, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Richard Kaiser Kaiser | CEO & CFO, Director | 1,424,447 | 4.25% | Sep 2, 2026 |
| Scott Mager | Director | 1,000,000 | 2.98% | Sep 3, 2026 |
| Merle Ferguson | Director | 16,470,000 | 49.09% | Sep 2, 2026 |
| Nexus Capital Investments, Inc. | 10% owner | 26,700,000 | 79.59% | Sep 4, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Richard Kaiser Kaiser CEO & CFO, Director | Aug 31, 2026 | Award | +316,909 | $0.55 | $174.30K | 1,234,447 |
| Richard Kaiser Kaiser CEO & CFO, Director | Aug 20, 2026 | Other | −38,462 | $0.65 | $25.00K | 917,538 |
| Merle Ferguson Director | Apr 22, 2026 | Sale | −26,700,000 | $0.02 | $534.00K | 0 |
| Merle Ferguson Director | Apr 20, 2026 | Gift | +4,132,000 | – | – | 26,700,000 |
| Merle Ferguson Director | Apr 20, 2026 | Gift | +20,580,000 | $0.01 | $205.80K | 22,568,000 |
| Richard Kaiser Kaiser CEO & CFO, Director | Apr 20, 2026 | Gift | −4,132,000 | – | – | 956,000 |
| Merle Ferguson CEO, Director, 10% owner | Oct 18, 2023 | Gift | +1,400,000 | – | – | 17,870,000 |
| Merle Ferguson CEO, Director, 10% owner | Oct 17, 2023 | Gift | +1,470,000 | – | – | 16,470,000 |
| Merle Ferguson CEO, Director, 10% owner | Oct 17, 2023 | Gift | −1,470,000 | – | – | 15,000,000 |
| Merle Ferguson CEO, Director, 10% owner | May 12, 2023 | Gift | −500,000 | – | – | 16,470,000 |
| Merle Ferguson CEO, Director, 10% owner | Dec 13, 2022 | Gift | −20,000 | – | – | 16,970,000 |
| Merle Ferguson CEO, Director, 10% owner | Sep 30, 2022 | Gift | −10,000 | – | – | 16,990,000 |
| Richard Kaiser Kaiser CFO, Director, 10% owner | Dec 4, 2020 | Award | +3,000,000 | – | – | 5,050,000 |
| Merle Ferguson CEO, Director, 10% owner | Dec 4, 2020 | Award | +11,000,000 | – | – | 15,000,000 |
| Richard Kaiser Kaiser CFO, Director, 10% owner | Dec 4, 2020 | Award | +3,000,000 | – | – | 5,050,000 |
| Richard Kaiser Kaiser CFO, Director, 10% owner | Dec 4, 2020 | Award | +3,000,000 | – | – | 5,050,000 |
| Richard Kaiser Kaiser CFO, Director, 10% owner | Dec 4, 2020 | Award | +3,000,000 | – | – | 5,050,000 |
| Merle Ferguson CEO, Director, 10% owner | Dec 4, 2020 | Award | +11,000,000 | – | – | 15,000,000 |
| Merle Ferguson CEO, Director, 10% owner | Dec 4, 2020 | Award | +11,000,000 | – | – | 15,000,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.